trial · primary record
Psilocybin
Transdiagnostic
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 50 |
| Primary completion | 2027-12 |
| Primary endpoint | Columbia-Suicide Severity Rating Scale (C-SSRS) |
| Registry ID | NCT06442423 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:17.390Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06442423
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Psilocybin · compound